2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Cell Therapy Manufacturing: Overcoming Scalability Issues

Production must be scaled up to meet patient demand for cell therapies while ensuring product quality and safety. Productive manufacturing techniques can lower charges while increasing accessibility. The biggest challenges include keeping cell quality consistent, following standards, and fabricating huge quantities at a high cost. Experts are implementing standardized protocols, streamlining systems, and improving cultural conditions to improve scalability and expedite manufacturing steps.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis